Literature DB >> 24401495

Biological mesh in contaminated fields--overuse without data: a systematic review of their use in abdominal wall reconstruction.

Wirt Cross1, Ajay Kumar, Gopal Chandru Kowdley.   

Abstract

Ventral hernia repair in contaminated fields is a significant problem for surgeons. We performed a systematic review regarding the use of biological mesh in contaminated fields for abdominal wall reconstruction. The primary end points were recurrence and infection of the hernia repair. An independent search of scientific papers in the English language was performed by three reviewers. Articles were chosen based on reference to ventral hernias, their use in infected fields, and in human subjects. Papers were scored using the Methodological Index for Non-Randomized Studies and those with a score of 8 or more were combined to evaluate the end points. A total of 16 studies from six different mesh products met our criteria. These papers comprised 554 patients with an overall infection rate of 24 per cent and a recurrence rate of 20 per cent. The largest study used 116 patients. All papers were case series. Overall the data for use of biological mesh products in contaminated fields are limited. Further controlled studies are needed to address this important and clinically relevant question. Caution should be used when using biological mesh products in infected fields because there is a paucity of controlled data and none have U.S. Food and Drug Administration approval for use in infected fields.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24401495

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

Review 1.  Surgical mesh for ventral incisional hernia repairs: Understanding mesh design.

Authors:  Ali Rastegarpour; Michael Cheung; Madhurima Vardhan; Mohamed M Ibrahim; Charles E Butler; Howard Levinson
Journal:  Plast Surg (Oakv)       Date:  2016       Impact factor: 0.947

2.  An evaluation of clinical and quality of life outcomes after ventral hernia repair with poly-4-hydroxybutyrate mesh.

Authors:  A N Christopher; M P Morris; V Patel; J A Mellia; C Fowler; C A Messa; R B Broach; J P Fischer
Journal:  Hernia       Date:  2021-04-27       Impact factor: 4.739

3.  Outcomes of biologic versus synthetic mesh in CDC class 3 and 4 open abdominal wall reconstruction.

Authors:  Michael Katzen; Sullivan A Ayuso; Jana Sacco; Dau Ku; Gregory T Scarola; Kent W Kercher; Paul D Colavita; Vedra A Augenstein; B Todd Heniford
Journal:  Surg Endosc       Date:  2022-08-04       Impact factor: 3.453

4.  Use of polypropylene mesh in contaminated and dirty strangulated hernias: short-term results.

Authors:  H Pandey; D S Thakur; U Somashekar; R Kothari; P Agarwal; D Sharma
Journal:  Hernia       Date:  2018-08-25       Impact factor: 4.739

Review 5.  Biologic Mesh in Surgery: A Comprehensive Review and Meta-Analysis of Selected Outcomes in 51 Studies and 6079 Patients.

Authors:  David J Samson; Mahir Gachabayov; Rifat Latifi
Journal:  World J Surg       Date:  2021-01-08       Impact factor: 3.352

6.  Biologic vs Synthetic Mesh for Single-stage Repair of Contaminated Ventral Hernias: A Randomized Clinical Trial.

Authors:  Michael J Rosen; David M Krpata; Clayton C Petro; Alfredo Carbonell; Jeremy Warren; Benjamin K Poulose; Adele Costanzo; Chao Tu; Jeffrey Blatnik; Ajita S Prabhu
Journal:  JAMA Surg       Date:  2022-04-01       Impact factor: 16.681

7.  Soft Tissue Repair with Easy-Accessible Autologous Newborn Placenta or Umbilical Cord Blood in Severe Malformations: A Primary Evaluation.

Authors:  Åsa Ekblad; Magdalena Fossum; Cecilia Götherström
Journal:  Stem Cells Int       Date:  2017-12-17       Impact factor: 5.443

Review 8.  What is the evidence for the use of biologic or biosynthetic meshes in abdominal wall reconstruction?

Authors:  F Köckerling; N N Alam; S A Antoniou; I R Daniels; F Famiglietti; R H Fortelny; M M Heiss; F Kallinowski; I Kyle-Leinhase; F Mayer; M Miserez; A Montgomery; S Morales-Conde; F Muysoms; S K Narang; A Petter-Puchner; W Reinpold; H Scheuerlein; M Smietanski; B Stechemesser; C Strey; G Woeste; N J Smart
Journal:  Hernia       Date:  2018-01-31       Impact factor: 4.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.